Skip to main content

Adia Med, Inc.

corporate_fare Company Profile

Adia Med, Inc.

ADIA·OTC·Life Sciences·CIK 0001160420

Adia Nutrition, Inc. provides medical treatments and nutritional supplements. The company operates through three segments: Biolete, Adia Med, and Adia Labs. Its Biolete segment offers autologous hematopoietic stem cell transplantation (AHSCT) treatments specifically for patients with multiple sclerosis. The Adia Med segment functions as a clinic where these stem cell treatments are performed. The Adia Labs segment is responsible for procuring and selling stem cell products, both to external clinics and to Adia Med. In addition to these medical services, Adia Nutrition, Inc. also offers a range of nutritional supplements and biologic products. The company distributes its products directly to consumers and through other direct-to-consumer channels. Adia Nutrition, Inc. was previously known as PivX Solutions Inc. and adopted its current name in May 2004. The company's headquarters are located in Winter Park, Florida.

Adia Med, Inc. (OTC:ADIA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for ADIA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for ADIA spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Adia Med Q3 10-Q: Going Concern Warning Persists Despite Revenue Nearly Doubling
  • CEO Buys 7% of Adia Labs Subsidiary for $350K Cash in Related-Party Deal
  • Adia Med Sells 30% of Adia Labs for $1.5M, Cedes Equal Voting Control
  • Adia Med Moves to Cancel 30.78% of Its Own Shares as Invalidly Issued
  • Adia Nutrition Q2 2026: Going Concern Warning, Ineffective Controls, and New Preferred Issuance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$700.51K
Net Income
-$395.46K
Diluted EPS
$0.00
Op. Cash Flow
-$179.23K
Free Cash Flow
-$192.43K
Gross Profit
$191.67K
Operating Income
-$366.49K
Cash & Equivalents
$79.39K
Debt / Equity
0.00×
Net Margin
-56.5%
Shares Outstanding
93.6M sh
Source: 10-K · filed 2026-03-31 · accession 0001683168-26-002531

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,460 shares in ADIA as of the October 30, 2026 settlement, a 91.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 50.6% of ADIA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,460 shares as of October 30, 2026
Change vs prior period▼ 91.8%
Days to cover1.00 at avg daily volume of 37,520
Daily short volume (FINRA facilities)50.6% of 3,184 shares on November 19, 2026
4-day average short volume67.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$0.111 -10.48% today
52-week range · as of 2026-11-16 $0.0225 – $0.2777
Market cap
$10.48M
Volume
2K (0.1× avg)
3-mo avg 37.3K
Live data · 2026-11-22 07:23 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ADIA - Latest Insights

ADIA
Nov 16, 2026, 2:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.128
Real-time Price: $0.111 info
Change: -$0.017 (-13%) info
Market Cap: $10.479M info
ADIA
Oct 19, 2026, 11:22 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.130
Real-time Price: $0.111 info
Change: -$0.019 (-15%) info
Market Cap: $10.479M info
ADIA
Oct 05, 2026, 7:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.101
Real-time Price: $0.111 info
Change: +$0.0100 (+10%) info
Market Cap: $10.479M info
ADIA
Oct 05, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.101
Real-time Price: $0.111 info
Change: +$0.0100 (+10%) info
Market Cap: $10.479M info
ADIA
Aug 13, 2026, 11:28 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1195
Real-time Price: $0.111 info
Change: -$0.0085 (-7%) info
Market Cap: $10.479M info
ADIA
May 26, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.160
Real-time Price: $0.111 info
Change: -$0.049 (-31%) info
Market Cap: $10.479M info
ADIA
May 14, 2026, 9:32 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.170
Real-time Price: $0.111 info
Change: -$0.059 (-35%) info
Market Cap: $10.479M info
ADIA
May 05, 2026, 10:08 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.150
Real-time Price: $0.111 info
Change: -$0.039 (-26%) info
Market Cap: $10.479M info
ADIA
Apr 08, 2026, 8:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.113
Real-time Price: $0.111 info
Change: -$0.0020 (-2%) info
Market Cap: $10.479M info
ADIA
Mar 31, 2026, 3:49 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.100
Real-time Price: $0.111 info
Change: +$0.011 (+11%) info
Market Cap: $10.479M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets